Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to compare the time to delivery of two different cervical ripening methods on the preterm gestation.
Condition or disease
Premature BirthCervical Ripening
Drug: MisoprostolDevice: Foley bulb
Labor induction for the preterm gestation is indicated for various maternal and fetal indications. The preterm cervix, however, is frequently not favorable for induction. Multiple methods have been evaluated in the term gestation. As these comparison studies have not included the preterm gestation, this study seeks to evaluate these two methods in terms of safety, efficacy and time to delivery.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 45 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
singleton gestation, gestational age 23-35 weeks, indication for induction
multiple gestation, non-cephalic presentation, previous uterine surgery, rupture of membranes, intrauterine fetal death